These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16728943)

  • 21. Surgical management of inflammatory breast cancer.
    Singletary SE
    Semin Oncol; 2008 Feb; 35(1):72-7. PubMed ID: 18308148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.
    Cristofanilli M; Valero V; Buzdar AU; Kau SW; Broglio KR; Gonzalez-Angulo AM; Sneige N; Islam R; Ueno NT; Buchholz TA; Singletary SE; Hortobagyi GN
    Cancer; 2007 Oct; 110(7):1436-44. PubMed ID: 17694554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer.
    Carbone PP; Bailey HH
    Cancer Chemother Biol Response Modif; 1994; 15():581-605. PubMed ID: 7779601
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on cancer therapy.
    Loh KK
    Hawaii Med J; 1988 Aug; 47(8):376. PubMed ID: 3049448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Guideline 'Treatment of breast cancer 2008' (revision)].
    Struikmans H; Nortier JW; Rutgers EJ; Zonderland HM; Bontenbal M; Elkhuizen PH; van Tienhoven G; Tjan-Heijnen VC; van Vegchel T; Tuut MK; Benraadt J
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2507-11. PubMed ID: 19055257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
    Rajkumar T; Samson M; Rama R; Sridevi V; Mahji U; Swaminathan R; Nancy NK
    Breast Cancer Res Treat; 2008 Nov; 112(1):81-7. PubMed ID: 18058229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of locally advanced breast cancer. Mini-review.
    Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
    Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concerns on diagnosis and treatment of breast cancer in China.
    Wang SM
    Chin Med J (Engl); 2007 Oct; 120(20):1741-2. PubMed ID: 18028763
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of treating patients with breast cancer].
    Ostrovtsev LD; Demidov VP; Pak DD; Stranadko EF; Komissarov AB
    Khirurgiia (Mosk); 1987 Sep; (9):21-6. PubMed ID: 3695246
    [No Abstract]   [Full Text] [Related]  

  • 31. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast sarcoma--a review of diagnosis and management.
    Pencavel TD; Hayes A
    Int J Surg; 2009 Feb; 7(1):20-3. PubMed ID: 19114317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of inflammatory breast cancer.
    Levine PH; Veneroso C
    Semin Oncol; 2008 Feb; 35(1):11-6. PubMed ID: 18308141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIMP-1 as a tumor marker in breast cancer--an update.
    Würtz SO; Schrohl AS; Mouridsen H; Brünner N
    Acta Oncol; 2008; 47(4):580-90. PubMed ID: 18465326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer. Breast Oncology Workgroup, Legislative Task Force on Cancer in Texas.
    Brown GR; Askew RE; Gallager HS; Hortobagyi GN; Montague ED; Neff LE; Osborne CK; Race GJ; Salem RJ; Townsend CM
    Tex Med; 1987 Sep; 83(9 Pt 2):81-96. PubMed ID: 3672409
    [No Abstract]   [Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy for locally advanced breast cancer.
    Specht J; Gralow JR
    Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
    Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and outcomes of isolated axillary node recurrence in breast cancer.
    Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
    Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.